Skip to main content

Find Clinical Trials

Home
Conditions
Multiple Sclerosis

Clinical trial condition

Multiple Sclerosis

Explore clinical trials studying Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

2,012 public trials 296 recruiting studies

Refine in advanced search Browse all conditions

Multiple Sclerosis trial results

Completed

Resilience in Young Adults Newly Diagnosed With Multiple Sclerosis

NCT03825055

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Azienda Ospedaliera Universitaria Integrata Verona, Policlinico G.B. Rossi Verona, Veneto, Italy

View Trial Details

Completed

Characterization of Early Patients Initiating Ofatumumab for Treatment of Multiple Sclerosis.

NCT05576779

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, COVID-19, +16 more
Locations: Novartis Investigative Site East Hanover, New Jersey, United States

View Trial Details

Completed

Risk Perception in Multiple Sclerosis

NCT05528666

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Novartis Investigative Site East Hanover, New Jersey, United States

View Trial Details

Completed

Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to Treat Multiple Sclerosis

NCT00246324

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: LSU Health Sciences Center Shreveport Shreveport, Louisiana, United States

View Trial Details

Completed

Early Exercise Efforts in Multiple Sclerosis

NCT03322761

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Behavior, +6 more
Locations: Section for Sport Science, Department of Public Health, University of Aarhus Aarhus, Denmark

View Trial Details

Completed

Estimating Prevalence of COVID-19 Infection and SARS-CoV-2 Antibodies in MS Patients

NCT04682548

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, COVID-19, +17 more
Locations: NYU Langone Health New York, United States

View Trial Details

Completed

Accurate Diagnosis of Multiple Sclerosis Using PET/MR

NCT04521439

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Shanghai Ruijin Hospital Shanghai, China

View Trial Details

Completed

Efficacy and Safety of Xacrel® (Ocrelizumab) in Participants With Relapsing Remitting Multiple Sclerosis

NCT04966338

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations: Qaem International Hospital Rasht, Gilan Province, Iran

Golestan Hospital Ahvāz, Khozestan, Iran

Bouali Hospital, MS Clinic Sari, Mazandaran, Iran

Qaem Hospital Mashhad, Razavi Khorasan Province, Iran

View all 15 locations

View Trial Details

Completed

Natural History of Multiple Sclerosis and Its Mimickers

NCT02504840

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Analysis of the Distribution of Regulatory B Cells in Blood of Multiple Sclerosis Patients

NCT02789670

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Connective Tissue Diseases, +9 more
Locations: CHRU de Lille Lille, France

View Trial Details